Kengi Itinose

Rivaroxaban versus no anticoagulation for post-discharge thromboprophylaxis after hospitalisation for COVID-19 (MICHELLE): an open-label, multicentre, randomised, controlled trial

Eduardo Ramacciotti, Leandro Barile Agati, Daniela Calderaro et al. · The Lancet · 2021 · 252 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +13

Meplazumab in hospitalized adults with severe COVID-19 (DEFLECT): a multicenter, seamless phase 2/3, randomized, third-party double-blind clinical trial

Huijie Bian, Liang Chen, Zhaohui Zheng et al. · Signal Transduction and Targeted Therapy · 2023 · 17 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +12

Efficacy and safety of Ixekizumab vs. low-dose IL-2 vs. Colchicine vs. standard of care in the treatment of patients hospitalized with moderate-to-critical COVID-19: A pilot randomized clinical trial (STRUCK: Survival Trial Using Cytokine Inhibitors)

Lívia Pimenta Bonifácio, Eduardo Ramacciotti, Leandro Barile Agati et al. · Revista da Sociedade Brasileira de Medicina Tropical · 2023 · 12 citations · Full text

Veterinary Medicine, Immunology, Pharmacotherapy +15